Fire Promotion Month, everyone practice!
Release time:
2022-11-23
Huang Ping Jianfeng Online Fire Safety Training
News In order to further enhance the knowledge of enterprise employees on fire safety accident prevention and emergency treatment, and to curb the occurrence of large fire accidents, 11# June 8 , Huang Ping Jianfeng Cement Company organized employees to participate in the 119 fire safety online live training conducted by Qiandongnan Prefecture Industry and Information Bureau.
This training adopts the form of online live broadcast, and explains the current safety situation and typical accident case analysis, self-examination and key points of enterprise fire hazards, emergency handling methods, understanding and using methods of conventional safety facilities, through on-site explanation, live commentary and real-time feedback, employees are helped to have a deeper understanding of the theme of this training -"Grasp fire safety and ensure high-quality development " . (Liu Zhonghua)
Yunnan Jianfeng Mine Fire Safety TrainingNews 11 8 , Yunnan Jianfeng Cement Company organized mine construction units to carry out mine fire safety training. In the training process of
, the lecturers mainly summarized the actual situation of the mine, and explained the main fire situation such as forest fire, vehicle fire, electrical fire and hot work fire, as well as the prevention and disposal of each fire, requiring all the staff on the scene to strictly implement the document spirit of the full safety production responsibility system and study carefully, and apply what you have learned to real work. The speaker also explained the daily maintenance, maintenance and use of fire extinguishers. (Zhao Guijin)
Jianfeng Pharmaceutical Co., Ltd. participated in the fire fighting competitionNews 11 8 -11 , the Qiubin Factory of Jianfeng Pharmaceutical Co., Ltd. sent personnel to participate in the 4th Mini Fire Station Skills Competition held by Jinhua Economic and Technological Development Zone.
This competition is divided into enterprise group and non-enterprise group, which will be held in group matches and finals respectively. The competition consists of two parts: a theoretical competition and a practical competition, in which the practical competition sets up three items: 40 m two-plate water belt connection exercise, 100 m evacuation material rescue exercise, and 3 × 50 m relay fire fighting exercise. In the end, Jianfeng Pharmaceutical advanced to the finals with the tenth place in the preliminaries and achieved the eighth place in the finals. (Ye Yujing)
Jianfeng Pharmaceutical Fire Accident Escape ExerciseNews from our newspaper 11 February 14 , the production department of Jianfeng Pharmaceutical Company carried out fire escape drills and on-site use teaching of fire fighting equipment in powder injection workshops and comprehensive warehouses.
This exercise simulates the occurrence of sudden fire accidents in the production process of the workshop. The workshop organizes and deals with emergencies in a timely manner, and controls and reduces personnel and property damage in the shortest time and the most effective way. The purpose of this exercise is to enable employees to effectively establish fire awareness, truly master the overall operation process of emergency fighting and rescue at the scene of a fire accident, and have the ability to respond to self-rescue and mutual rescue and deal with emergencies, and be organized, orderly, and quickly Guide employees to evacuate safely and quickly, and master the correct method of escape.
This drill also organized new employees and employees of the powder injection workshop to teach the use of fire fighting equipment to ensure that employees can correctly use fire fighting equipment and enhance their ability to extinguish initial fires.
(Xu JianboYe Yujing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page